RAPP; Moritz
Patent Applications and Registrations
Patent applications and USPTO patent grants for RAPP; Moritz.The latest application filed is for "bispecific antigen binding molecules comprising anti-fap clone 212".
- RAPP; Moritz - Zurich CH
- Rapp; Moritz - Schlieren CH
| Patent | Date |
|---|---|
| Bispecific Antigen Binding Molecules Comprising Anti-fap Clone 212 App 20220227878 - BRUENKER; Peter ; et al. | 2022-07-21 |
| Bispecific antigen binding molecules comprising anti-FAP clone 212 Grant 11,242,396 - Bruenker , et al. February 8, 2 | 2022-02-08 |
| Bispecific Antigen Binding Molecules With Trivalent Binding To Cd40 App 20210292426 - DUERR; Harald ; et al. | 2021-09-23 |
| Novel Bispecific Antigen Binding Molecules Capable Of Specific Binding To Cd40 And To Fap App 20210188992 - BRUENKER; Peter ; et al. | 2021-06-24 |
| Bispecific antigen binding molecules comprising anti-FAP clone 212 App 20200190207 - BRUENKER; Peter ; et al. | 2020-06-18 |
| Novel Bispecific Antigen Binding Molecules Capable Of Specific Binding To Cd40 And To Fap App 20180340030 - BRUENKER; Peter ; et al. | 2018-11-29 |
| Cxcr6-transduced T Cells For Targeted Tumor Therapy App 20180256645 - KOBOLD; Sebastian ; et al. | 2018-09-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 